Ray Dalio's ADNT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 290,099 shares of Adient plc (ADNT) worth $5.86 M, representing 0.03% of the portfolio. First purchased in 2019-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in ADNT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 432,443 shares. Largest reduction occurred in Q1 2026, reducing 139,181 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Adient plc (ADNT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adient plc (ADNT) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -139,181 | Reduce 32.42% | 290,099 | $20.21 |
| Q4 2025 | -3,163 | Reduce 0.73% | 429,280 | $19.17 |
| Q3 2025 | +432,443 | New Buy | 432,443 | $24.08 |
| Q3 2022 | -66,124 | Sold Out | 0 | $0.00 |
| Q2 2022 | -2,272 | Reduce 3.32% | 66,124 | $29.63 |
| Q1 2022 | -17,214 | Reduce 20.11% | 68,396 | $40.78 |
| Q4 2021 | -56,958 | Reduce 39.95% | 85,610 | $47.88 |
| Q3 2021 | +50,766 | Add 55.30% | 142,568 | $41.45 |
| Q2 2021 | -6,894 | Reduce 6.99% | 91,802 | $45.20 |
| Q1 2021 | +98,696 | New Buy | 98,696 | $44.20 |
| Q4 2020 | -24,934 | Sold Out | 0 | $0.00 |
| Q3 2020 | +4,695 | Add 23.20% | 24,934 | $17.33 |
| Q2 2020 | -1,378 | Reduce 6.37% | 20,239 | $16.40 |
| Q1 2020 | -10,386 | Reduce 32.45% | 21,617 | $9.07 |
| Q4 2019 | +32,003 | New Buy | 32,003 | $21.25 |
Ray Dalio's Adient plc Investment FAQs
Ray Dalio first purchased Adient plc (ADNT) in Q4 2019, acquiring 32,003 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Adient plc (ADNT) for 15 quarters since Q4 2019.
Ray Dalio's largest addition to Adient plc (ADNT) was in Q3 2025, adding 432,443 shares worth $10.41 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 290,099 shares of Adient plc (ADNT), valued at approximately $5.86 M.
As of the Q1 2026 filing, Adient plc (ADNT) represents approximately 0.03% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Adient plc (ADNT) was 432,443 shares, as reported at the end of Q3 2025.